ArticleBMC neurology2011

Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.

Matthias Löhle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.